Stay updated with breaking news from Bioscience Segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Grifols, S.A. (NASDAQ:GRFS – Get Rating) fell 2% on Tuesday . The company traded as low as $8.54 and last traded at $8.64. 98,387 shares were traded during mid-day trading, a decline of 89% from the average session volume of 899,347 shares. The stock had previously closed at $8.82. Analyst Ratings Changes A […]
Grifols, S.A. (NASDAQ:GRFS – Get Rating) has been given an average rating of “Moderate Buy” by the nine research firms that are covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price objective […]
Grifols, S.A. (NASDAQ:GRFS – Get Rating) gapped up before the market opened on Friday . The stock had previously closed at $8.34, but opened at $8.90. Grifols shares last traded at $8.88, with a volume of 45,725 shares traded. Analysts Set New Price Targets A number of research firms have recently commented on GRFS. Barclays […]
StockNews.com began coverage on shares of Grifols (NASDAQ:GRFS – Get Rating) in a research note released on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. GRFS has been the topic of a number of other reports. Morgan Stanley upgraded shares of Grifols from an equal weight rating to an overweight […]
StockNews.com started coverage on shares of Grifols (NASDAQ:GRFS – Get Rating) in a research report released on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. GRFS has been the topic of a number of other reports. Barclays upgraded shares of Grifols from an underweight rating to an equal weight rating in […]